Cerebral Venous Sinus Stenting for the Treatment of Idiopathic Intracranial Hypertension in a Child

Abstract

Idiopathic intracranial hypertension (IIH) is a disease characterized by an increase in the opening pressure of the cerebrospinal fluid (CSF) associated with symptoms of elevated intracranial pressure (ICP). The condition is more prevalent in women and typically managed clinically. Surgical treatment is reserved for select refractory cases. The well-established surgical procedures for the management of IIH are CSF shunting and fenestration of the optic nerve sheath. These procedures, however, are associated with high rates of complication and recurrence.

More recently, venous sinus angioplasty with stents has been employed in cases with documented narrowing of the sigmoid-transverse sinuses. This technique is associated with a significant reduction in the venous pressure gradient at the stenosis site, alleviating the symptoms of intracranial hypertension.

We report a case of a previously healthy 12-year-old patient who presented with 10-day history of headaches, blurring of vision, nausea and vomiting, which evolved with worsening of the visual acuity and papilledema. Imaging scans disclosed stenosis of the right transverse and sigmoid sinuses. The patient underwent stenting of the stenotic venous segments and showed good evolution, with significant clinical improvement within 24 hours of the procedure.

Resumo

A hipertensão intracraniana idiopática (HII) é uma doença caracterizada pelo aumento da pressão de abertura do líquido cefalorraquidiano associado a sintomas de aumento da pressão intracraniana. É mais frequente em mulheres, sendo habitualmente tratada com medidas clínicas. O tratamento cirúrgico é reservado a uma minoria de casos que se mostram refratários. Os procedimentos cirúrgicos consagrados para este fim são a derivação liquórica e a fenestração de bainha do nervo óptico. Entretanto, eles estão associados a altos índices de complicações e recorrência.

Mais recentemente, a angioplastia de seio venoso com uso do stent vem sendo utilizada em casos em que há redução documentada no calibre dos seios transverso-sigmoide com repercussão comprovada no gradiente pressórico. Essa técnica está associada a uma redução significativa no gradiente de pressão venosa no local da estenose. Consequentemente, resulta em alívio dos sintomas da hipertensão intracraniana.

Neste trabalho, descrevemos o caso de um paciente de 12 anos de idade, sem doenças prévias, que apresentava quadro de cefaleia, turvação visual, náuseas e vômitos de início havia dez dias, tendo evoluído com piora da acuidade visual e papiledema. Realizou exame de imagem que identificou estenose dos seios transversos e sigmoide à direita. O paciente foi submetido a angioplastia dos segmentos venosos estenosados, apresentando boa evolução, com melhora clínica significativa já nas primeiras 24 horas após o procedimento.

Keywords

intracranial hypertension - papilledema - pseudotumor cerebri - intracranial thrombosis - endovascular procedures

Palavras-chave

hipertensão intracraniana - papiledema - pseudotumor cerebral - trombose intracraniana - procedimentos endovasculares

Publication History

Received: 25 September 2020

Accepted: 21 January 2021

Article published online:
28 September 2022

• References

• 1 Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59 (10) 1492-1495
• 2 McGeeney BE, Friedman DI. Pseudotumor cerebri pathophysiology. Headache 2014; 54 (03) 445-458
• 3 Elder BD, Goodwin CR, Kosztowski TA. et al. Venous sinus stenting is a valuable treatment for fulminant idiopathic intracranial hypertension. J Clin Neurosci 2015; 22 (04) 685-689
• 4 Dinkin MJ, Patsalides A. Venous sinus stenting in idiopathic intracranial hypertension : results of a prospective trial. J Neuroophthalmol 2017; 37 (02) 113-121
• 5 Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45 (08) 875-877
• 6 Acheson JF. Idiopathic intracranial hypertension and visual function. Br Med Bull 2006; 79-80: 233-244
• 7 Warner JEA, Larson AJ, Bhosale P. et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 2007; 27 (04) 258-262
• 8 Binder DK, Horton JC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery 2004; 54 (03) 538-551 , discussion 551–552
• 9 Galgano MA, Deshaies EM. An update on the management of pseudotumor cerebri. Clin Neurol Neurosurg 2013; 115 (03) 252-259
• 10 Hornby C, Mollan SP, Botfield H, OʼReilly MW, Sinclair AJ. OʼReilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol 2018; 38 (04) 522-530
• 11 Al-Mufti F, Dodson V, Amuluru K. et al. Neuroendovascular cerebral sinus stenting in idiopathic intracranial hypertension. Intervent Neurol 2020; 8 (2-6): 164-171
• 12 Satti SR, Leishangthem L, Chaudry MI. Meta-Analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2015; 36 (10) 1899-1904
• 13 Daggubati LC, Liu KC. Intracranial venous sinus stenting: a review of idiopathic intracranial hypertension and expanding indications. Cureus 2019; 11 (02) e4008
• 14 Gurney SP, Ramalingam S, Thomas A, Sinclair AJ, Mollan SP. Exploring the current management idiopathic intracranial hypertension, and understanding the role of dural venous sinus stenting. Eye Brain 2020; 12: 1-13
• 15 Ding D, Starke RM, Durst CR, Crowley RW, Liu KC. Venous stenting with concurrent intracranial pressure monitoring for the treatment of pseudotumor cerebri. Neurosurg Focus 2014; 37 (1, Suppl): 1
• 16 Miyachi S, Hiramatsu R, Ohnishi H, Takahashi K, Kuroiwa T. Endovascular treatment of idiopathic intracranial hypertension with stenting of the transverse sinus stenosis. Neurointervention 2018; 13 (02) 138-143
• 17 Giridharan N, Patel SK, Ojugbeli A. et al. Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature. Neurosurg Focus 2018; 45 (01) E10
• 18 Saber H, Lewis W, Sadeghi M, Rajah G, Narayanan S. Stent survival and stent-adjacent stenosis rates following venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. Intervent Neurol 2018; 7 (06) 490-500
• 19 Silva JMA, Conti MLM, Aguiar GB. et al. Endovascular treatment for idiopathic intracranial hypertension improves clinical symptoms and signs. Arq Bras Neurocir 2017; 36: 1-6